Skip to main
HUM
HUM logo

Humana (HUM) Stock Forecast & Price Target

Humana (HUM) Analyst Ratings

Based on 17 analyst ratings
Hold
Strong Buy 6%
Buy 29%
Hold 65%
Sell 0%
Strong Sell 0%

Bulls say

Humana's positive outlook is supported by an increase in the 2025 earnings per share (EPS) estimate to $17.06, reflecting strong second-quarter results and revised guidance. The company's anticipated year-over-year earnings growth for 2027 is driven by the implementation of margin initiatives, despite estimated stability in Star ratings and the absence of recovered bonus payments. Additionally, Humana's commitment to environmental sustainability is noteworthy, as the company has surpassed its goals with a reduction of over 20% in greenhouse gas emissions since 2017, highlighting its operational efficiency and long-term strategic planning.

Bears say

Humana's management anticipates a slight decline in earnings per share (EPS) for 2026 compared to 2025, primarily due to ongoing challenges related to the Stars program, despite efforts to enhance margins. Furthermore, a downside scenario suggests that EPS for fiscal year 2027 could be approximately 10% lower than estimates, attributable to increased investments aimed at supporting recovery in the Stars program. The company's reliance on government-sponsored programs and the potential for a benefit gap amid competitive pressures also contribute to a cautious outlook on its financial stability moving forward.

Humana (HUM) has been analyzed by 17 analysts, with a consensus rating of Hold. 6% of analysts recommend a Strong Buy, 29% recommend Buy, 65% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Humana and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Humana (HUM) Forecast

Analysts have given Humana (HUM) a Hold based on their latest research and market trends.

According to 17 analysts, Humana (HUM) has a Hold consensus rating as of Oct 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $296.06, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $296.06, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Humana (HUM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.